{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:46:45Z","timestamp":1793252805198,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017531","name":"GITAM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112613","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T08:33:28Z","timestamp":1719909208000},"page":"112613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["CD44\/PD-L1-mediated networks in drug resistance and immune evasion of breast cancer stem cells: Promising targets of natural compounds"],"prefix":"10.1016","volume":"138","author":[{"given":"RamaRao","family":"Malla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kattula","family":"Jyosthsna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganji","family":"Purnachandra Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2024.112613_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6030077","article-title":"Breast Cancer Stem Cells","volume":"6","author":"Crabtree","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2024.112613_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-030-14366-4_5","article-title":"Heterogeneity and plasticity of breast cancer stem cells","author":"Sousa","year":"2019","journal-title":"Stem Cells Heterogeneity in Cancer"},{"key":"10.1016\/j.intimp.2024.112613_b0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.21037\/sci.2017.11.03","article-title":"Breast cancer stem cells-from origins to targeted therapy","volume":"4","author":"Sin","year":"2017","journal-title":"Stem Cell Investig"},{"issue":"7","key":"10.1016\/j.intimp.2024.112613_b0020","first-page":"4173","article-title":"Expression of ALDH1 and TGF\u03b22 in benign and malignant breast tumors and their prognostic implications","volume":"7","author":"Zheng","year":"2014","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","article-title":"Cancer Stem Cells: The Architects of the Tumor Ecosystem","volume":"24","author":"Prager","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0030","first-page":"313","article-title":"Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression\/Evasion","volume":"25","author":"Dzobo","year":"2021","journal-title":"Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis, Omics"},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","article-title":"CD44 as a tumor biomarker and therapeutic target","volume":"9","author":"Xu","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12943-018-0809-x","article-title":"Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2024.112613_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123765","article-title":"Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.intimp.2024.112613_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.856974","article-title":"Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance","volume":"12","author":"Saha","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2024.112613_b0055","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65418","article-title":"Association of human breast cancer CD44(-)\/CD24(-) cells with delayed distant metastasis","volume":"10","author":"Qiao","year":"2021","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0060","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3892\/ijo.2017.4129","article-title":"Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)","volume":"51","author":"Katoh","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10911-014-9323-y","article-title":"Breast cancer stem cells and the immune system: promotion, evasion and therapy","volume":"19","author":"Boyle","year":"2014","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"10","key":"10.1016\/j.intimp.2024.112613_b0070","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3390\/cancers15102689","article-title":"Comparison of Clinical Subtypes of Breast Cancer within the Claudin-Low Molecular Cluster Reveals Distinct Phenotypes","volume":"15","author":"Voutsadakis","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050040","article-title":"HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance","volume":"9","author":"Nami","year":"2017","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050720","article-title":"Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer","volume":"12","author":"Landeros","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112613_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115887","article-title":"Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil","volume":"437","author":"Nandi","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112613_b0090","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/15384047.2016.1190488","article-title":"Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment","volume":"17","author":"Wang","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.intimp.2024.112613_b0095","doi-asserted-by":"crossref","first-page":"1026278","DOI":"10.3389\/fonc.2022.1026278","article-title":"ALDH1: A potential therapeutic target for cancer stem cells in solid tumors","volume":"12","author":"Wei","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112613_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030576","article-title":"Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights","volume":"11","author":"Uprety","year":"2022","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.intimp.2024.112613_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246209","article-title":"The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer","volume":"13","author":"He","year":"2021","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.intimp.2024.112613_b0110","doi-asserted-by":"crossref","unstructured":"D.B. Tukaramrao, S. Malla, S. Saraiya, R.A. Hanely, A. Ray, S. Kumari, D. Raman, A.K. Tiwari, A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells, Cancers (Basel) 13(8) (2021).","DOI":"10.3390\/cancers13081954"},{"key":"10.1016\/j.intimp.2024.112613_b0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jconrel.2021.04.029","article-title":"Improving anti-PD-L1 therapy in triple negative breast cancer by polymer-enhanced immunogenic cell death and CXCR4 blockade","volume":"334","author":"Zhou","year":"2021","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mc.23277","article-title":"Breast cancer stem cells: A review of their characteristics and the agents that affect them","volume":"60","author":"Shan","year":"2021","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.intimp.2024.112613_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.112613_b0130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell-immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2024.112613_b0135","doi-asserted-by":"crossref","first-page":"5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"issue":"4","key":"10.1016\/j.intimp.2024.112613_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040970","article-title":"Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression","volume":"14","author":"Ponomarev","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2024.112613_b0145","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3389\/fonc.2020.01122","article-title":"Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment","volume":"10","author":"D'Angelo","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BD-190409","article-title":"Role of CD44 in breast cancer","volume":"39","author":"Al-Othman","year":"2020","journal-title":"Breast Dis."},{"issue":"7","key":"10.1016\/j.intimp.2024.112613_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/biom13071047","article-title":"Prediction of CD44 Structure by Deep Learning-Based Protein Modeling","volume":"13","author":"Camponeschi","year":"2023","journal-title":"Biomolecules"},{"issue":"3\u20134","key":"10.1016\/j.intimp.2024.112613_b0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1101\/gad.319889.118","article-title":"CD44 splice isoform switching determines breast cancer stem cell state","volume":"33","author":"Zhang","year":"2019","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.intimp.2024.112613_b0165","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.5966\/sctm.2015-0048","article-title":"Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target","volume":"4","author":"Yan","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"7","key":"10.1016\/j.intimp.2024.112613_b0170","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/cas.12967","article-title":"CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment","volume":"107","author":"Thanee","year":"2016","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0175","doi-asserted-by":"crossref","first-page":"C68","DOI":"10.1152\/ajpcell.00094.2014","article-title":"CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions","volume":"308","author":"Shirure","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.intimp.2024.112613_b0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2017.00018","article-title":"CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells","volume":"5","author":"Senbanjo","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112613_b0185","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1074\/jbc.RA119.010252","article-title":"Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation","volume":"295","author":"Kawaguchi","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2024.112613_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091849","article-title":"Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells","volume":"18","author":"Bourguignon","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0195","first-page":"145","volume":"28","author":"Zhang","year":"2022","journal-title":"CD44 Promotes Angiogenesis in Myocardial Infarction through Regulating Plasma Exosome Uptake and Further Enhancing FGFR2 Signaling Transduction"},{"issue":"13","key":"10.1016\/j.intimp.2024.112613_b0200","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.7150\/ijbs.23586","article-title":"Novel CD44-downstream signaling pathways mediating breast tumor invasion","volume":"14","author":"Ouhtit","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"34","key":"10.1016\/j.intimp.2024.112613_b0205","doi-asserted-by":"crossref","first-page":"36762","DOI":"10.18632\/oncotarget.5461","article-title":"CD44-mediated activation of \u03b15\u03b21-integrin, cortactin and paxillin signaling underpins adhesion of basal-like breast cancer cells to endothelium and fibronectin-enriched matrices","volume":"6","author":"McFarlane","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/2159-8290.CD-18-0065","article-title":"Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models","volume":"9","author":"Liu","year":"2019","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.intimp.2024.112613_b0215","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/0008-5472.CAN-19-2288","article-title":"Breast Cancer Cell-Derived Soluble CD44 Promotes Tumor Progression by Triggering Macrophage IL1\u03b2 Production","volume":"80","author":"Jang","year":"2020","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2024.112613_b0220","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41419-020-03037-0","article-title":"CD44\/HA signaling mediates acquired resistance to a PI3K\u03b1 inhibitor","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.intimp.2024.112613_b0225","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/iub.2608","article-title":"Hyaluronan as \u201cAgent Smith\u201d in cancer extracellular matrix pathobiology: Regulatory roles in immune response, cancer progression and targeting","volume":"74","author":"Kokoretsis","year":"2022","journal-title":"IUBMB Life"},{"issue":"8","key":"10.1016\/j.intimp.2024.112613_b0230","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.21873\/anticanres.16526","article-title":"CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma","volume":"43","author":"Ma","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.intimp.2024.112613_b0235","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.gene.2018.06.094","article-title":"Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells","volume":"675","author":"Al-Othman","year":"2018","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.intimp.2024.112613_b0240","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3892\/ijo.2016.3639","article-title":"CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer","volume":"49","author":"Xu","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112613_b0245","doi-asserted-by":"crossref","first-page":"e106966","DOI":"10.1371\/journal.pone.0106966","article-title":"NF-\u03baB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112613_b0250","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.redox.2018.04.015","article-title":"High CD44 expression mediates p62-associated NFE2L2\/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance","volume":"17","author":"Ryoo","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2024.112613_b0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2015.12.005","article-title":"The Wnt signaling pathway in cancer","volume":"99","author":"Duchartre","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112613_b0260","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/cdd.2014.156","article-title":"CD44 functions in Wnt signaling by regulating LRP6 localization and activation","volume":"22","author":"Schmitt","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2024.112613_b0265","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/1471-2407-10-414","article-title":"Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells","volume":"10","author":"Uchino","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","article-title":"Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2024.112613_b0275","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3892\/or.2017.5834","article-title":"Snail maintains metastatic potential, cancer stem-like properties, and chemoresistance in mesenchymal mouse breast cancer TUBO-P2J cells","volume":"38","author":"Ma","year":"2017","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2024.112613_b0280","doi-asserted-by":"crossref","first-page":"14089","DOI":"10.18632\/oncotarget.12923","article-title":"The crosstalk between microRNAs and the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112613_b0285","doi-asserted-by":"crossref","first-page":"17039","DOI":"10.1038\/cddiscovery.2017.39","article-title":"BMP-2 induces EMT and breast cancer stemness through Rb and CD44","volume":"3","author":"Huang","year":"2017","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0290","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41419-017-0037-0","article-title":"How BMP-2 induces EMT and breast cancer stemness through Rb and CD44?","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.intimp.2024.112613_b0295","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.3892\/mmr.2016.5856","article-title":"The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+\/CD24- phenotype","volume":"14","author":"Zhao","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2024.112613_b0300","first-page":"2147","article-title":"The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-\/low subpopulation and the side population of breast cancer cells","volume":"29","author":"Tanaka","year":"2009","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.intimp.2024.112613_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040375","article-title":"Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics","volume":"8","author":"Riobo-Del Galdo","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.intimp.2024.112613_b0310","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/CS20140592","article-title":"The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients","volume":"129","author":"He","year":"2015","journal-title":"Clin. Sci. (lond.)"},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0315","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/0008-5472.CAN-09-1681","article-title":"Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor","volume":"70","author":"Harrison","year":"2010","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0320","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7150\/thno.66148","article-title":"Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1\/moesin-mediated inhibition of TGF\u03b2\/FN1\/CD44 signaling","volume":"12","author":"Sun","year":"2022","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.intimp.2024.112613_b0325","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/0008-5472.CAN-19-1108","article-title":"CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers","volume":"80","author":"Kong","year":"2020","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/vco.12884","article-title":"Tumour necrosis factor stimulated gene 6 intrinsically regulates PD-L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment","volume":"21","author":"Lee","year":"2023","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.intimp.2024.112613_b0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.freeradbiomed.2018.11.030","article-title":"The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen","volume":"131","author":"Zheng","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.112613_b0340","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-015-0421-2","article-title":"Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells","volume":"14","author":"Alsuliman","year":"2015","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0345","doi-asserted-by":"crossref","first-page":"9657","DOI":"10.1038\/s41598-023-33915-4","article-title":"CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis","volume":"13","author":"Liu","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2024.112613_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092361","article-title":"The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure","volume":"10","author":"Galassi","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.intimp.2024.112613_b0355","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/cam4.3902","article-title":"Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells","volume":"10","author":"Shi","year":"2021","journal-title":"Cancer Med."},{"issue":"21","key":"10.1016\/j.intimp.2024.112613_b0360","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/s41388-019-0700-2","article-title":"WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer","volume":"38","author":"Castagnoli","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0365","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/jcp.30135","article-title":"Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells","volume":"236","author":"Aboulkheyr Es","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0370","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/1440-1681.12732","article-title":"Increased PD-L1 expression in breast and colon cancer stem cells","volume":"44","author":"Wu","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2024.112613_b0375","first-page":"3958908","article-title":"PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications","author":"Darvin","year":"2019","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0380","doi-asserted-by":"crossref","first-page":"1729299","DOI":"10.1080\/2162402X.2020.1729299","article-title":"PD-L1 is overexpressed on breast cancer stem cells through notch3\/mTOR axis","volume":"9","author":"Mansour","year":"2020","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.intimp.2024.112613_b0385","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/ijc.30834","article-title":"PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K\/AKT pathway activation","volume":"141","author":"Almozyan","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2024.112613_b0390","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41388-021-02144-2","article-title":"PD-L1 interacts with Frizzled 6 to activate \u03b2-catenin and form a positive feedback loop to promote cancer stem cell expansion","volume":"41","author":"Fu","year":"2022","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.intimp.2024.112613_b0395","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13543784.2022.2049232","article-title":"Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer","volume":"31","author":"Agostinetto","year":"2022","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"23","key":"10.1016\/j.intimp.2024.112613_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11236996","article-title":"Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy","volume":"11","author":"Lo Iacono","year":"2022","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112613_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030656","article-title":"Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action","volume":"18","author":"Aung","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.intimp.2024.112613_b0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228480","article-title":"Natural Health Products (NHP's) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends","volume":"21","author":"Scaria","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2024.112613_b0415","first-page":"970","article-title":"Natural and herbal compounds targeting breast cancer, a review based on cancer stem cells","volume":"23","author":"Bozorgi","year":"2020","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.112613_b0420","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/bph.14816","article-title":"Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence","volume":"177","author":"Lin","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112613_b0425","article-title":"Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways, Molecules (Basel","volume":"27","author":"Yang","year":"2022","journal-title":"Switzerland)"},{"issue":"23","key":"10.1016\/j.intimp.2024.112613_b0430","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.3390\/ijms222313044","article-title":"Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics","volume":"22","author":"Meerson","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2024.112613_b0435","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.7314\/APJCP.2013.14.10.6089","article-title":"Genomic screening for targets regulated by berberine in breast cancer cells","volume":"14","author":"Wen","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.intimp.2024.112613_b0440","article-title":"Transcriptome profiling of curcumin-treated T47D human breast cancer cells by a system-based approach","volume":"27","author":"Khazei","year":"2022","journal-title":"Gene Rep"},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0445","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-016-3854-4","article-title":"Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention","volume":"158","author":"Colacino","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0450","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020457","article-title":"Flavonoids as Anticancer Agents","volume":"12","author":"Kopustinskiene","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2024.112613_b0455","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J Nutr Sci"},{"issue":"4","key":"10.1016\/j.intimp.2024.112613_b0460","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15384101.2021.2020434","article-title":"Chrysin impairs genomic stability by suppressing DNA double-strand break repair in breast cancer cells","volume":"21","author":"Geng","year":"2022","journal-title":"Cell Cycle"},{"issue":"23","key":"10.1016\/j.intimp.2024.112613_b0465","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313044","article-title":"Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics","volume":"22","author":"Meerson","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2024.112613_b0470","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/febs.14084","article-title":"Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs","volume":"284","author":"Manupati","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.intimp.2024.112613_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2019.107156","article-title":"In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents","volume":"83","author":"Debnath","year":"2019","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112613_b0480","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.2147\/DDDT.S181939","article-title":"Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K\/AKT pathway in vivo and vitro","volume":"12","author":"Yan","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2024.112613_b0485","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.743837","article-title":"Baicalein Potentiated M1 Macrophage Polarization in Cancer Through Targeting PI3K\u03b3\/ NF-\u03baB Signaling","volume":"12","author":"He","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112613_b0490","first-page":"1528","article-title":"Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization","volume":"8","author":"Zhao","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2024.112613_b0495","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1002\/ctm2.577","article-title":"Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1\u03b1","volume":"11","author":"Chen","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.intimp.2024.112613_b0500","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s11010-022-04597-9","article-title":"Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1","volume":"478","author":"Hua","year":"2023","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.intimp.2024.112613_b0505","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030624","article-title":"Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2","volume":"11","author":"Koh","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2024.112613_b0510","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2147\/DDDT.S102541","article-title":"Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt\/\u03b2-catenin pathway","volume":"10","author":"Ma","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2024.112613_b0515","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3892\/mco.2016.750","article-title":"Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis","volume":"4","author":"Yan","year":"2016","journal-title":"Molecular and Clinical Oncology"},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0520","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2010.04.022","article-title":"Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells","volume":"297","author":"Wang","year":"2010","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.intimp.2024.112613_b0525","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1002\/jcb.26881","article-title":"Baicalein inhibits breast cancer growth via activating a novel isoform of the long noncoding RNA PAX8-AS1-N","volume":"119","author":"Yu","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.intimp.2024.112613_b0530","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/gtc.12584","article-title":"Baicalein disturbs the morphological plasticity and motility of breast adenocarcinoma cells depending on the tumor microenvironment","volume":"23","author":"Terabayashi","year":"2018","journal-title":"Genes Cells"},{"issue":"12","key":"10.1016\/j.intimp.2024.112613_b0535","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1248\/bpb.b20-00571","article-title":"Anti-metastatic Effects of Baicalein by Targeting STAT3 Activity in Breast Cancer Cells","volume":"43","author":"Susmitha","year":"2020","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0540","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3892\/ol.2017.6298","article-title":"Baicalein, unlike 4-hydroxytamoxifen but similar to G15, suppresses 17\u03b2-estradiol-induced cell invasion, and matrix metalloproteinase-9 expression and activation in MCF-7 human breast cancer cells","volume":"14","author":"Chen","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.112613_b0545","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3109\/10717544.2015.1031295","article-title":"Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy","volume":"23","author":"Liu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2024.112613_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122778","article-title":"Nano-baicalein facilitates chemotherapy in breast cancer by targeting tumor microenvironment","volume":"635","author":"Zheng","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2024.112613_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123209","article-title":"Ratiometric codelivery of Paclitaxel and Baicalein loaded nanoemulsion for enhancement of breast cancer treatment","volume":"643","author":"Yadav","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2024.112613_b0560","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41420-018-0124-8","article-title":"Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP\/TAZ activity","volume":"4","author":"Li","year":"2018","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.intimp.2024.112613_b0565","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1007\/s11030-022-10384-x","article-title":"Kaempferol and Apigenin suppresses the stemness properties of TNBC cells by modulating Sirtuins","volume":"26","author":"Sharma","year":"2022","journal-title":"Mol. Divers."},{"issue":"21","key":"10.1016\/j.intimp.2024.112613_b0570","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216452","article-title":"Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway","volume":"26","author":"Tsai","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112613_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110462","article-title":"Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP\/TAZ activity","volume":"129","author":"Cao","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112613_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173210","article-title":"Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells","volume":"881","author":"Monti","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112613_b0585","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s40064-015-1242-x","article-title":"Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts","volume":"4","author":"Cook","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.intimp.2024.112613_b0590","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2018.01.014","article-title":"Quercetin suppresses breast cancer stem cells (CD44(+)\/CD24(-)) by inhibiting the PI3K\/Akt\/mTOR-signaling pathway","volume":"196","author":"Li","year":"2018","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.intimp.2024.112613_b0595","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.31557\/APJCP.2022.23.12.4145","article-title":"Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells","volume":"23","author":"Azizi","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.intimp.2024.112613_b0600","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbrc.2023.03.077","article-title":"Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of Smad2\/Smad3 phosphorylation and \u03b2-catenin signaling pathway in triple-negative breast cancer","volume":"664","author":"Hatami","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2024.112613_b0605","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/ptr.6081","article-title":"Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation","volume":"32","author":"Li","year":"2018","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2024.112613_b0610","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.biopha.2018.02.055","article-title":"Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it","volume":"100","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.intimp.2024.112613_b0615","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.3390\/ijms25105556","article-title":"Molecular Pathways of Genistein Activity in Breast Cancer Cells","volume":"25","author":"Konstantinou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.112613_b0620","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3892\/ijo.2016.3351","article-title":"Genistein-induced differentiation of breast cancer stem\/progenitor cells through a paracrine mechanism","volume":"48","author":"Liu","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112613_b0625","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/acs.jafc.5b00002","article-title":"Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene","volume":"63","author":"Wu","year":"2015","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0630","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjms.2017.03.001","article-title":"Epigallocatechin-3-Gallate: The Prospective Targeting of Cancer Stem Cells and Preventing Metastasis of Chemically-Induced Mammary Cancer in Rats","volume":"354","author":"Abd El-Rahman","year":"2017","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0635","first-page":"39","article-title":"Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NF\u03baB signaling","volume":"35","author":"Chung","year":"2015","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0640","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12951-021-00934-0","article-title":"Novel CD44-targeting and pH\/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis","volume":"19","author":"Shi","year":"2021","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"10.1016\/j.intimp.2024.112613_b0645","first-page":"3767","article-title":"Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells","volume":"31","author":"Kim","year":"2011","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0650","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune Checkpoint Inhibitors in Cancer Therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"issue":"21","key":"10.1016\/j.intimp.2024.112613_b0655","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study","volume":"34","author":"Nanda","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0660","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-019-1326-5","article-title":"Recent advances in triple negative breast cancer: the immunotherapy era","volume":"17","author":"Marra","year":"2019","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0665","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/jnci\/djab121","article-title":"Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130","volume":"114","author":"Badve","year":"2022","journal-title":"J. Natl Cancer Inst."},{"issue":"17","key":"10.1016\/j.intimp.2024.112613_b0670","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176176","article-title":"Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review","volume":"21","author":"Haibe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112613_b0675","article-title":"Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells","volume":"36 Suppl 1","author":"Adinew","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2024.112613_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153737","article-title":"Anticancer effects of asiatic acid against doxorubicin-resistant breast cancer cells via an AMPK-dependent pathway in vitro","volume":"92","author":"Zhu","year":"2021","journal-title":"Phytomedicine : International Journal of Phytotherapy and Phytopharmacology"},{"issue":"5","key":"10.1016\/j.intimp.2024.112613_b0685","doi-asserted-by":"crossref","DOI":"10.3390\/nu13051718","article-title":"Polyphenols Modulating Effects of PD-L1\/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer","volume":"13","author":"Messeha","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.intimp.2024.112613_b0690","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.canlet.2016.06.023","article-title":"Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells","volume":"380","author":"Coombs","year":"2016","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2024.112613_b0695","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12935-021-02345-5","article-title":"To explore immune synergistic function of Quercetin in inhibiting breast cancer cells","volume":"21","author":"Qiu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2024.112613_b0700","first-page":"9078209","article-title":"Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1\/Nanog In Vitro","volume":"2019","author":"Zhang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2024.112613_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109988","article-title":"Brazilein inhibits epithelial-mesenchymal transition (EMT) and programmed death ligand 1 (PD-L1) expression in breast cancer cells","volume":"118","author":"Wudtiwai","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112613_b0710","doi-asserted-by":"crossref","unstructured":"P. Kongtawelert B. Wudtiwai T.H. Shwe P. Pothacharoen T. Phitak Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer, Molecules 25 2020 (Basel, Switzerland).","DOI":"10.3390\/molecules25020252"},{"key":"10.1016\/j.intimp.2024.112613_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106759","article-title":"Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin","volume":"86","author":"Kongtawelert","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112613_b0720","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1158\/2326-6066.CIR-19-0228","article-title":"Trifluridine\/Tipiracil plus Oxaliplatin Improves PD-1 blockade in colorectal cancer by inducing immunogenic cell death and depleting macrophages","volume":"7","author":"Limagne","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112613_b0725","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-19-0517","article-title":"Combined CD44- and CD25-targeted near-infrared photoimmunotherapy selectively kills cancer and regulatory T cells in syngeneic mouse cancer models","volume":"8","author":"Maruoka","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112613_b0730","article-title":"Immunogenic cell death-relevant damage-associated molecular patterns and sensing receptors in triple-negative breast cancer molecular subtypes and implications for immunotherapy","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2024.112613_b0735","doi-asserted-by":"crossref","first-page":"9053274","DOI":"10.1155\/2020\/9053274","article-title":"Cordyceps militaris induces immunogenic cell death and enhances antitumor immunogenic response in breast cancer","volume":"2020","author":"Quan","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.112613_b0740","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1039\/C9CC08447A","article-title":"Photothermal therapy-induced immunogenic cell death based on natural melanin nanoparticles against breast cancer","volume":"56","author":"Li","year":"2020","journal-title":"Chem. Commun. (camb)"},{"issue":"11","key":"10.1016\/j.intimp.2024.112613_b0745","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1021\/acsnano.3c02287","article-title":"Melanin-based immunoregulatory nanohybrids enhance antitumor immune responses in breast cancer mouse model","volume":"17","author":"Guo","year":"2023","journal-title":"ACS Nano"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T13:36:42Z","timestamp":1722346602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924011342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":149,"alternative-id":["S1567576924011342"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112613","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD44\/PD-L1-mediated networks in drug resistance and immune evasion of breast cancer stem cells: Promising targets of natural compounds","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112613"}}